Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Taste receptor type 2 member 39 (TAS2R39) is a member of the bitter taste receptor family, a sub-group of G protein-coupled receptors that function primarily to detect harmful or bitter compounds ingested as part of the diet. TAS2R39 is encoded by an intronless gene located on chromosome 7 and, while historically thought to act only in the oral cavity, is also expressed in extraoral tissues including the gastrointestinal tract, respiratory tract, nervous system, and reproductive system, albeit at low levels. TAS2R39 is activated by a broad range of compounds, especially plant-derived polyphenols and certain bile acids, and can modulate various physiological responses such as bitterness perception, hormone secretion (notably peptide PYY), and possibly inflammation. Its non-selectivity and wide ligand profile make it a potentially interesting target for research on nutrient sensing, metabolism, and immune responses, but its biological and therapeutic relevance remains underexplored due to restricted expression and the lack of selective pharmaceutics.
Compounds binding to TAS2R39 induce a conformational change that activates the gustducin-linked GPCR pathway, leading to phospholipase C β2 activation, increased intracellular calcium, and neurotransmitter (ATP) release. Downstream effects can include modulation of appetite-regulating hormones (e.g., PYY), inflammatory signal induction, and sensory perception.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Taste receptor type 2 member 39 (TAS2R39).